ClinicalTrials.govpublic full text
TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
lymphomas, solid tumors, nsclc, metastatic colon carcinoma, granulosa cell ovarian cancer, dna damage, pharmacodynamics, pharmacokinetics, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 907031
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.